References
- Penston JG, Pounder RE. A survey of dyspepsia in Great Britain. Aliment Pharmacol Ther 1996;10:83–9.
- Johansson K-E, Ask P, Boeryd B, Fransson S-G, Tibbling L. Oesophagitis, signs of reflux and gastric acid secretion in patients with symptoms of gastro-oesophageal reflux disease. Scand J Gastroenterol 1986;21:837–47.
- Hedenstrom H, Alm C, Kraft M, Grahnen A. Intragastric pH after oral administration of single doses of ranitidine effervescent tablets, omeprazole capsules and famotidine fast-dissolving tablets to fasting healthy volunteers. Aliment Pharmacol Ther 1997;11:1137–41.
- Arnestad JS, Kleveland PM, Waldum HL. In single doses ranitidine effervescent is more effective than lansoprazole in decreasing gastric acidity. Aliment Pharmacol Ther 1997;11:355–8.
- Devis G, De Rop H, Du Ville L, Van Avermaet S, Kaufman L, Derde M-P, et al. Fast onset of action on the intragastric pH with ranitidine effervescent tablets. Arch Int Pharmacodyn 1993;322:124–8.
- Watson RG, Johnston BT, Tham TC, Kersey K. Effervescent and standard formulations of ranitidine. A comparison of their pharmacokinetics and pharmacology. Aliment Pharmacol Ther 1996;10:913–8.
- Engzelius JM, Solhaug JH, Knapstad LJ, Kjaersgaard P. Ranitidine effervescent and famotidine wafer in the relief of episodic symptoms of gastro-oesophageal reflux disease. Scand J Gastroenterol 1997;32:513–8.